This company's heart disease technology is gaining traction. The post This ASX biotech has just announced a major US deal appeared first on The Motley Fool Australia.

A new AI model, Mythos, drastically shrinks the time between discovering and exploiting software vulnerabilities, creating a ...

With AI and big tech firms seeking to raise hundreds of billions in equity and debt this year to build data centers, any high ...

Current HOS regulations rely on manual clocks and paper-log logic. A Dynamic Hours of Service framework uses biometric ...

JSW Motors and Tata Elxsi have formed a partnership aimed at supporting the development of software-defined and AI-led mobility in India.

After multiple years of strong gains, Palantir Technologies (PLTR +0.13%) stock is finally slowing down. Since the start of ...

Many of the most successful players in the AI arena, such as CoreWeave, Nvidia and AMD, are making the chips and memory ...

Shares of International Business Machines (NYSE:IBM | IBM Price Prediction) are being left out of the latest AI party, thanks ...

PhantomCore exploited three TrueConf flaws since September 2025, enabling remote access and lateral movement across Russian ...

Geely Auto Group attended Auto China 2026 (Beijing Auto Show) for the first time directly as an exhibitor and showcased the ...

Nvidia taking an ~8% stake signals real strategic validation for Nokia’s AI-RAN and software-defined network push (anyRAN + ...

The company now expects 2026 adjusted earnings to come in between $21.80 and $22.05 per share, up from its earlier range of ...